Patients share GPs' worry over Government policies
Treatment with statins is cost-effective for many more patients than are receiving the drugs now, researchers conclude.
The influential Heart Protection Study group found using statins in patients with vascular disease or diabetes red- uced hospitalisation costs by 22 per cent.
The cost of avoiding a major vascular event was estimated to be £11,600 overall.
The study, published online by The Lancet this week,
concluded that the risk threshold for statins should be lowered.
Study co-ordinator Dr Jane Armitage, a reader in clinical epidemiology at the University of Oxford, said: 'What our data shows is that anybody at risk of heart disease and that includes adults with diabetes is likely to benefit from cholesterol lowering.'